Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

Chet Holmgren to miss 8-10 weeks after tendon treatment

Published 1 November 2026

Oklahoma City Thunder center Chet Holmgren is expected to miss eight to 10 weeks after receiving biological treatment for a small tear in his right patellar tendon, the team said. The Thunder announced the treatment on October 30, after Holmgren experienced knee discomfort and consulted specialists. They did not identify the specific procedure. The team said the treatment was successful and that Holmgren is expected to make a full recovery before returning to play. The reported timetable would keep him out for much of the early portion of the 2026-27 NBA season. The Thunder did not announce a specific return date. Holmgren had missed Oklahoma City’s previous two games after reporting discomfort on October 25, according to the team. One report, citing an unnamed league source, identified the treatment as platelet-rich plasma therapy; the Thunder’s update did not specify that method. The injury adds to Oklahoma City’s absences. Cason Wallace underwent surgery on October 30 for a torn labrum in his left shoulder and is to be reevaluated before the end of the regular season. Forward Jalen Williams had surgery after fracturing his left fibula and dislocating his left ankle. The...

Now playing
0:00 / 0:00